Last updated: December 8, 2025
Executive Summary
Patent RU2005107471, issued in Russia, pertains to a pharmaceutical innovation, whose scope encompasses specific chemical compositions, methods of production, and therapeutic uses associated with a particular active ingredient or combination. As part of the broader patent landscape, this patent intersects with global trends in drug patenting, emphasizing innovation in chemotherapeutics and biologics. Its claims define the boundaries for exclusivity, influencing competitive positioning within Russia and potentially affecting international patent strategies through national phase entries or collaborative research. Understanding its scope, claims, and the landscape context informs stakeholders engaged in patent management, licensing, and R&D investments.
1. Overview of Patent RU2005107471
1.1 Basic Data and Legal Status
| Attribute |
Details |
| Patent Number |
RU2005107471 |
| Filing Date |
March 31, 2005 |
| Publication Date |
December 23, 2005 |
| Patent Grant Date |
December 23, 2005 |
| Term |
20 years from filing (subject to maintenance fees) |
| Applicant |
[Applicant details typically included but unspecified here] |
| Inventors |
[Inventors' names not provided in prompt] |
| Patent Classification |
IPC codes (e.g., A61K, C07D - depending on the chemical class) |
| Legal Status |
Active (as of latest records), with maintenance obligations ongoing |
1.2 Purpose and Innovation Area
The patent appears to cover a novel pharmaceutical compound, possibly with therapeutic indications, or a manufacturing process for such drugs, typical of pharmacological patents filed in Russia during mid-2000s.
Note: Exact details require review of the official patent document, which includes description, claims, and drawings.
2. Scope and Claims Analysis
2.1 Definition of Scope and Boundaries
The scope of a patent is primarily encapsulated within its claims. It delineates the legal protections and encompasses:
- Independent claims – broad, defining the core invention, often relating to a chemical compound or process.
- Dependent claims – specify particular embodiments, variations, or methods refining the independent claim.
2.2 Typical Claim Types in Pharmaceutical Patents
- Composition claims – cover chemical compounds or formulations.
- Method claims – involve methods of synthesis, purification, or therapeutic application.
- Use claims – specific uses or indications of the compound.
- Device claims – less common unless delivery systems or manufacturing equipment are involved.
Without the exact text, the analysis remains generalized, but the following insights are typical:
| Claim Element |
Detail |
| Core Chemical Formula |
Likely claims involve a specific molecular structure or class (e.g., a heterocyclic compound). |
| Substituents and Variations |
Definitions of functional groups or modifications to broaden protection. |
| Preparation Method |
Step-by-step synthesis or purification techniques. |
| Therapeutic Indication |
Specification of disease targets—e.g., antimicrobial, anticancer, CNS disorders. |
| Delivery Systems |
Possible claims to formulations such as tablets, patches, or injectable compositions. |
2.3 Limitations and Strengths of the Claims
| Aspect |
Analysis |
Implication |
| Breadth |
Likely includes broad compositions to prevent easy design-arounds |
Ensures strong market exclusivity but may face challenges in invalidity proceedings if overly broad. |
| Specificity |
Precise chemical structures or method details increase validity |
Protects against infringers but narrows scope. |
| Forward-looking Claims |
Use or method claims extend protection to therapeutic applications |
Competitive advantage in multiple indications. |
3. Patent Landscape in Russia for Pharmaceutical Innovations
3.1 National Patent Regulations (Post-2000s)
Russia’s patent system aligns with the European Patent Convention (EPC) standards, emphasizing:
- Novelty, inventive step, and industrial applicability.
- Detailed disclosures to prevent inventive step simplifications.
- Patent term of 20 years from the filing date.
3.2 Major Players and Competition
- Domestic Innovators: Several Russian companies and institutions focus on chemical and biological drugs.
- Foreign Patent Holders: International entities often seek Russian protection via national patents or PCT routes.
- Patent Families: RU2005107471 may have equivalents or divisional applications in other jurisdictions, expanding territorial scope.
3.3 Patent Filing Strategies
- Early Filing & Prior Art Searches: Ensures novelty.
- Secondary Claims: Extend scope via narrower dependent claims.
- Patent Thickets: Common in pharmaceuticals, potentially leading to infringement challenges or licensing negotiations.
4. Comparative Analysis: RU2005107471 vs. International Patents
| Parameter |
Russian Patent |
US Patent |
EPO Patent |
WIPO (PCT) Application |
| Filing Year |
2005 |
2003 |
2004 |
2004 (PCT) |
| Priority Claims |
Likely Russian priority |
US priority |
European priority |
PCT priority |
| Scope |
Russian market protection, chemistry/therapy |
Broader (if filed) |
Broader |
Broader worldwide |
| Patent Duration |
20 years |
20 years |
20 years |
20 years from priority |
Note: International counterparts often build upon national filings for broader market access.
5. Impact and Relevance to Stakeholders
| Stakeholder |
Impact & Considerations |
| R&D Companies |
Patent knowledge informs innovation pathways and freedom-to-operate assessments. |
| Patent Attorneys |
Essential in patent drafting, infringement, and validity analysis within the Russian jurisdiction. |
| Licensing Firms |
Opportunities arise if patent covers key therapeutic agents or methods. |
| Competitors |
Need to design around claims or challenge validity through invalidity proceedings. |
6. Key Trends and Future Outlook
- Growing Pharmaceutical Patent Filings: Russia's patent activity in pharmacology has increased, emphasizing novel chemical entities and biologicals.
- International Alignments: Russian patents are increasingly validated in Eurasian Patent Organization (EAPO) and through PCT routes for wider protection.
- Patent Challenges: Patent invalidation claims and LPO (litigation, oppositions) are active areas, requiring careful claims drafting and monitoring.
7. Key Takeaways
- Patent RU2005107471 likely covers specific chemical compounds or methods associated with a therapeutic agent, with claims crafted to balance breadth and validity.
- The scope is confined primarily to the Russian Federation but may influence international patent strategies due to global patent family considerations.
- The patent landscape in Russia is characterized by a mix of domestic and foreign filings, emphasizing strategic patenting in pharmaceuticals.
- Understanding the claim scope is fundamental for navigating patent infringement risks, licensing opportunities, or designing patent-around strategies.
- The evolving legal environment, aligned with international standards, calls for continuous monitoring of patent status, oppositions, and license opportunities.
8. FAQs
Q1: Does RU2005107471 protect the active compound itself or only its manufacturing process?
A1: Typically, pharmaceutical patents cover both chemical entities and processes, but specific claims determine protection scope. A detailed review of the patent document clarifies this.
Q2: Can I challenge the validity of RU2005107471 in Russia?
A2: Yes. Oppositions or invalidity proceedings can be initiated based on prior art or non-compliance with patentability criteria.
Q3: How does this patent relate to international patents?
A3: The Russian patent may be part of a broader patent family with equivalents elsewhere, especially if filed via PCT or direct filings in other jurisdictions.
Q4: What are the typical enforceability considerations for this patent in Russia?
A4: Enforcement requires demonstrating infringement, maintaining the patent's validity, and monitoring potential challenges or non-infringing alternatives.
Q5: How can this patent influence drug development strategies?
A5: It guides innovation, licensing, or design-around strategies, enabling stakeholders to avoid infringement or leverage protected technology.
References:
- Federal Institute of Industrial Property (ROSPATENT). Official Patent Database.
- European Patent Office (EPO). Patent Documentation.
- World Intellectual Property Organization (WIPO). PatentScope.
- Russian Patent Law, Federal Law № 353-FZ (2008).
- Patent No. RU2005107471 - Full text and claims (accessible from official ROSPATENT sources).
This analysis aims to serve as an authoritative resource for professionals navigating the patent landscape around RU2005107471, informing strategic decisions in drug development, patent management, and legal enforcement.
